Agence Nationale de Sécurité du Médicament et des Produits de Santé

Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM)[1] superseded the tasks and duties of Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS) on 1 May 2012.[2] It is responsible for assessing the benefits and risks associated with the use of health products throughout their life-cycle. ANSM assesses the safety, efficacy and quality of these products and must balance patient safety with access to novel therapies.

References

  1. "Accueil - ANSM : Agence nationale de sécurité du médicament et des produits de santé" (in French). Ansm.sante.fr. Retrieved 2013-11-26.
  2. Original TextMartine Lochouarn. "France launches new drug regulatory agency". The Lancet. Retrieved 2013-11-26.


This article is issued from Wikipedia - version of the Saturday, April 16, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.